Clinical Trial Update: Retrospective Follow-up of Synvisc® in Active Patients With Knee Osteoarthritis

View source ↗

Summary

This document provides retrospective follow-up data on the use of Synvisc (hylan G-F 20) in patients with osteoarthritis of the knee.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Synvisc (Hylan G-F 20)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Osteoarthritis | Status: COMPLETED